dry eye

How to know when it’s not dry eye
Achieving physiologic restoration in dry eyeTear osmolarity testing provides clinicians the opportunity to detect disease and select treatments to restore ocular surface health.
Hypochlorous acid eyelid wash reduces bacterial load
Hypochlorous acid eyelid wash reduces bacterial loadResearchers studied the magnitude of bacterial load reduction on the surface of the skin 20 minutes after application of saline containing 0.01% pure hypochlorous acid as the preservative to the skin below the lower eyelid.
Novel device provides rapid measure of tear osmolarityA new handheld, tear osmolarity device could enhance the convenience and reliability of dry eye screening and monitoring and be more affordable for many practices.
Topical ENaC blocker serves as novel approach to tear filmA novel potent epithelial sodium channel blocker seems to be a safe and well-tolerated therapy in patients with symptoms of mild-to-moderate dry eye disease compared with placebo.
New dry eye treatment demonstrates rapid onset symptomatic reliefResults from the Phase 3 OPUS-3 trial provide evidence confirming a benefit of lifitegrast ophthalmic solution 5.0% (Xiidra, Shire) for significantly improving dry eye disease-related symptoms, as measured by Eye Dryness Score.
Intense pulsed light shows therapeutic potential for MGD
Intense pulsed light shows therapeutic potential for MGDA series of treatments using intense pulsed light with optimal pulse technology may show potential in patients with meibomian gland dysfunction.
Sustained-release dexamethasone depot effective in lowering fluorescein stainingA dropless option for steroid therapy showed encouraging results in a phase II safety and efficacy study in patients with inflammatory dry eye disease.
Vectored thermal pulsation delivers long-lasting MGD improvementFollow-up from a study enrolling 200 patients with meibomian gland dysfuction showed a single treatment with vectored thermal pulsation afforded improvements in symptoms and meibomian gland function.
Semifluorinated alkane technology brings advantages for topical therapySemifluorinated alkane technology has novel physicochemical properties that explain its benefits as an ocular lubricant and support its use for developing a well-tolerated, preservative-free, multidose preparation of cyclosporine.